Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
APGE
Stock Latest News
Company Announcements
Apogee Therapeutics Shareholders Back Board, Auditors, Compensation
1d ago
8K
APGE
Premium
Ratings
Salveen Richter Reiterates Hold on Apogee; Maintains $89 Price Target Amid Long-Term Promise and Pipeline Uncertainty
3d ago
APGE
Premium
The Fly
Apogee Therapeutics price target raised to $97 from $82 at RBC Capital
6d ago
APGE
Premium
The Fly
Apogee Therapeutics moved to Neutral at Goldman Sachs
17d ago
APGE
Premium
Ratings
Analyst Reaffirms Buy on Apogee as Zumilokibart Data Strengthens Case; $137 Price Target Maintained
17d ago
APGE
Premium
The Fly
Apogee Therapeutics price target lowered to $81 from $83 at Truist
18d ago
APGE
Premium
The Fly
Apogee Therapeutics price target raised to $135 from $120 at Wedbush
18d ago
APGE
Premium
Company Announcements
Apogee Advances Zumilokibart After Positive Phase 2 Results
18d ago
8K
APGE
Premium
Company Announcements
Apogee Therapeutics Secures Major Non-Dilutive Blackstone Financing
18d ago
8K
APGE
Premium
The Fly
Apogee Therapeutics announces $1.3B financing pact with Blackstone Life Sciences
18d ago
APGE
Premium
The Fly
Apogee Therapeutics reports ‘positive’ results from Part B of Phase 2 APEX trial
18d ago
APGE
Premium
Ratings
Michael Yee Reaffirms Buy on Apogee, Citing Differentiated Zumilokibart Profile, Upcoming Data Catalysts, and Maintained $100 Price Target
1M ago
APGE
Premium
Ratings
Analyst Reiterates Buy on Apogee, Maintains $137 Price Target on Strong Zumilokibart Profile and Pipeline Upside
1M ago
APGE
Premium
The Fly
Apogee Therapeutics initiated with a Buy at Rothschild & Co Redburn
1M ago
APGE
Premium
Company Announcements
Apogee Therapeutics Announces Upcoming Board Resignations, Governance Shift
2M ago
8K
APGE
Premium
Ratings
APGE: Best-in-Class Potential for Zumilokibart in Atopic Dermatitis Supports Undervalued Buy Rating
2M ago
APGE
Premium
The Fly
Apogee Therapeutics price target raised to $110 from $105 at Mizuho
3M ago
APGE
Premium
Company Announcements
Apogee Therapeutics Prices Upsized Public Equity Offering
3M ago
8K
APGE
Premium
The Fly
Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
3M ago
GM
AMD
Premium
The Fly
Apogee Therapeutics 5M share Secondary priced at $70.00
3M ago
APGE
Premium
The Fly
Apogee Therapeutics price target raised to $118 from $108 at Deutsche Bank
3M ago
APGE
Premium
The Fly
Apogee Therapeutics price target raised to $160 from $130 at Guggenheim
3M ago
APGE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
